The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Junsong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, Chin…. Hauptthemen laut MEDLINE: Lung Neoplasms, Breast Neoplasms, Macrophage Migration-Inhibitory Factors, Intramolecular Oxidoreductases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Fundamental Research Funds for the Central Universities, The Special Fund for Basic Scientific Research of Central Colleges, Shanghai Jiaotong University for Nationalities', the "111 Center".
Abstract (Originalsprache)
Breast cancer, the most prevalent malignant tumour in women, is characterised by high metastatic potential and frequent recurrence, both of which significantly impact patient prognosis following metastasis. To address this challenge, identifying novel therapeutic target combinations is critical for improving metastatic breast cancer treatment. This study investigates the mechanism by which asparaginyl endopeptidase (AEP) regulates breast cancer metastasis. Bioinformatics analysis revealed a potential interaction between AEP and CD74, which was subsequently confirmed through co‐immunoprecipitation (co‐IP) experiments. Further investigations demonstrated that AEP activates ERK pathway phosphorylation via CD74 regulation, thereby enhancing epithelial‐mesenchymal transition (EMT) progression and promoting breast cancer cell migration. Compared to controls, dual inhibition of AEP and CD74 effectively reduced EMT markers and the migratory capacity of cancer cells in vitro. Subsequent in vivo experiments showed that this combinatorial strategy significantly suppressed breast cancer lung metastasis in mice without observable toxicity. These findings elucidate the molecular mechanism through which AEP promotes metastasis via CD74 regulation, while validating the therapeutic efficacy and safety of dual AEP/CD74 targeting. This study provides a novel conceptual framework and potential therapeutic targets for metastatic breast cancer intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Vascular Surgery, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
- Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Department of Radiotherapy, Huangpu Branch of the Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Junsong Chen
Förderung
- The Fundamental Research Funds for the Central Universities
- The Special Fund for Basic Scientific Research of Central Colleges, Shanghai Jiaotong University for Nationalities'
- the "111 Center"
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Chen, J., Xu, W., Meng, L., Zhang, X., Lin, M., Zhang, S., Liu, Y., & Guo, F. (2025). The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70616
Vancouver
Chen J, Xu W, Meng L, Zhang X, Lin M, Zhang S, et al. The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70616
BibTeX
@article{Chen2025,
author = {Chen, Junsong and Xu, Wenke and Meng, Luyang and Zhang, Xin and Lin, Mengyao and Zhang, Sheng and Liu, Yi and Guo, Fang},
title = {The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70616}
}
EUVIMED